Search results for

New York City's mayor wants to ban sugary drinks larger than 16 ounces from being sold at restaurants, delis and other venues to combat obesity. It's not the first time Mayor Bloomberg has taken on the soda industry. The announcement is prompting objections from beverage distributors — and from some New Yorkers who say they're fed up with the crusades of so-called Nanny Bloomberg.

Do you call it pop, soda or coke? Melissa Block and Robert Siegel have more on the regional battle over soft drink terminology.

The unveiling of George W. Bush's official painting at the White House brought the former president, his wife, father and mother back for the ceremony with the president and first lady.

Known for her soaring melodies and rich, rugged voice, the singer-songwriter performs songs from her new album, Bear Creek, in NPR's Studio 4A.

Heart of a Samurai tells the true story of 14-year-old Manjiro, a boy who was shipwrecked, rescued by whalers and taken to America. It was the late 1800s, when Japan was cut off from the outside world — until Manjiro returned and influenced the shogun to open the country to diplomacy.

At first blush, the trial looks like it might do little to deter politicians from getting money from supporters and, with some sleight of hand, spend it on practically anything. While the verdict was clearly a loss for prosecutors, analysts believe it wasn't a total loss for campaign finance law.

Recent court cases have changed the rules about money in federal politics, but there still are rules. Here's a snapshot of fundraising limits and regulations across the political spectrum — ranging from the candidates themselves to the new superPACs.

Top stories include a look at the U.S. job creation numbers for May, which were modest; and the UN's top commissioner for human rights warns Syria is on the precipice of civil war.

The blood of horseshoe crabs is bright blue, not red like ours. The "jack-of-all-trades" creatures are built to last, and the blood can do amazing things. That makes it incredibly valuable to drug companies and researchers.

Investors are reacting to the much-weaker-than-expected report on job growth in May.